NBIX- Neurocrine Biosciences, Inc.

Name: Neurocrine Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Gano Kyle	140.4K	$23.32M	-
Other	Benevich Eric	52.8K	$8.76M	-
Other	Lippoldt Darin	46.8K	$7.76M	-
Other	Cooke Julie	39.6K	$6.58M	-36,937
Other	Onyia Jude	36.8K	$6.12M	-22,000

Activity

Buys and sells only

Transactions

10 filings · page 24

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jan 26, 2021	Benevich Eric62	Chief Commercial Officer	Sale+OE	5,477	$120.02	$657,371.27	-7.8%
Jan 26, 2021	Lyons Gary A54	Director	Sell	2,000	$120.02	$240,046.56	-0.4%
Jan 8, 2021	Roberts Eiry49	Chief Medical Officer	Sell	2,632	$111.06	$292,297.29	-14.2%
Jan 8, 2021	Gorman Kevin Charles55	Chief Executive Officer	Sale+OE	308,250	$110.22	$33,973,876.51	-25.9%
Dec 1, 2020	Abernethy Matt57	Chief Financial Officer	Sell	1,645	$94.66	$155,720.96	-12.5%
Nov 12, 2020	Benevich Eric62	Chief Commercial Officer	Sell	2,257	$90.71	$204,722.99	-11.5%
Nov 12, 2020	Roberts Eiry49	Chief Medical Officer	Sell	2,257	$90.74	$204,809.89	-14.3%
Nov 12, 2020	Lloyd-Smith Malcolm49	Chief Regulatory Officer	Sell	2,257	$90.73	$204,775.80	-7.2%
Nov 12, 2020	Lippoldt Darin60	Chief Legal Officer	Sell	2,257	$90.72	$204,754.59	-7.0%
Nov 12, 2020	Grigoriadis Dimitri E.	Chief Research Officer	Sell	2,257	$90.73	$204,783.70	-2.7%

← PrevPage 24Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC